tiprankstipranks
Trending News
More News >
Asymchem Laboratories (Tianjin) Co., Ltd. Class H (HK:6821)
:6821
Hong Kong Market

Compare Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$73.80
HK$38.25B
43.80
25.06%
Genscript Biotech
HK$14.33
HK$24.51B
-6.48
-15.53%
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$50.93B
26.08
6.45%
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.76
HK$34.58B
-22.62
41.47%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$11.76
HK$30.53B
10.27
42.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$23.64B
33.55
89.51%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
76.60
22.00
40.29%
HK:1548
Genscript Biotech
11.10
-1.32
-10.63%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
18.48
2.34
14.46%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.90
7.70
54.23%
HK:2096
Simcere Pharmaceutical Group Limited
11.52
3.82
49.61%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
64.15
32.55
103.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts